Lessons learned from the emergence of a new Trypanosoma brucei rhodesiense sleeping sickness focus in Uganda.
- 1 January 2003
- journal article
- review article
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 3 (1) , 42-45
- https://doi.org/10.1016/s1473-3099(03)00488-2
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Treatment of human African trypanosomiasis—present situation and needs for research and developmentThe Lancet Infectious Diseases, 2002
- Identification of human-infective trypanosomes in animal reservoir of sleeping sickness in Uganda by means of serum-resistance-associated (SRA) geneThe Lancet, 2001
- The origins of a new Trypanosoma brucei rhodesiense sleeping sickness outbreak in eastern UgandaThe Lancet, 2001
- Sleeping sickness surveillance: an essential step towards eliminationTropical Medicine & International Health, 2001
- Pharmacokinetic investigations in patients from northern Angola refractory to melarsoprol treatmentTropical Medicine & International Health, 2001
- Financial priorities under decentralization in Uganda.Health Policy and Planning, 2001
- Sleeping sickness: a tale of two diseasesTrends in Parasitology, 2001
- The Biochemical Basis of Arsenical–Diamidine Crossresistance in African TrypanosomesParasitology Today, 1999
- Epidemiological relationships of Trypanosoma brucei stocks from South East Uganda: evidence for different population structures in human infective and non-human infective isolatesParasitology, 1994
- Arsenical-resistant trypanosomes lack an unusual adenosine transporterNature, 1993